CIK 0001796280 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -100.7 M | -89.1 M | -78.7 M | |
| Diluted EPS (USD/shares) | -1.47 | -1.96 | -2.25 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-21 | 4 | 4 | 2026-10-20 |
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-01 | 144 | 144 | |
| 2026-10-01 | 144 | 144 | |
| 2026-09-29 | 4 | 4 | 2026-09-28 |
| 2026-09-25 | 4 | 4 | 2026-09-24 |
| 2026-08-28 | 4 | 4 | 2026-08-26 |
| 2026-08-26 | 144 | 144 | |
| 2026-08-03 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-03 | 8-K | 8-K items 2.02,9.01 | 2026-08-03 |
| 2026-07-30 | S-8 | S-8 | |
| 2026-07-30 | 8-K | 8-K items 5.02,9.01 | 2026-07-28 |
| 2026-07-28 | 4 | 4 | 2026-07-24 |
| 2026-07-08 | 4 | 4 | 2026-07-06 |
| 2026-07-06 | 144 | 144 | |
| 2026-07-06 | 144 | 144 | |
| 2026-06-22 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-18 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-04 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-04 | 8-K | 8-K items 2.02,9.01 | 2026-05-04 |
| 2026-04-28 | ARS | ARS | 2025-12-31 |
Forms on file (last 1,000): 4 148, 8-K 64, SC 13G/A 23, 144 21, 10-Q 20, SC 13G 17, 3 15, SCHEDULE 13G/A 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ORIC (0.002 USD), /gw/filings/filings?ticker=ORIC&form=8-K, /gw/filings/facts?ticker=ORIC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange